RAS, BRAF, and TP53 Gene Mutations in Taiwanese Colorectal Cancer Patients

By  

Onkologie, Vol. 36, Iss. 12, 2013-11 ,pp. : 719-724

Karger

Access to resources Recommend Favorite

Detection of the TP53 Tumour Suppressor Gene Product and p53 Auto-antibodies in the Ascites of Women with Ovarian Cancer

By Angelopoulou K.   Diamandis E.P.  

European Journal of Cancer, Vol. 33, Iss. 1, 1997-01 ,pp. : 115-121

Elsevier

Access to resources Recommend Favorite

Identification of TP53 Gene Mutations in Uterine Corpus Cancer with Short Follow-up

By Koul A.   Borg A.   Pejovic T.   Bendahl P.-O.   Hogberg T.   Iosif C.S.   Killander D.  

Gynecologic Oncology, Vol. 67, Iss. 3, 1997-12 ,pp. : 295-302

Elsevier

Access to resources Recommend Favorite

Detection of the human papillomavirus and analysis of the TP53 polymorphism of exon 4 at codon 72 in penile squamous cell carcinomas

By Humbey O.   Cairey-Remonnay S.   Guerrini J.S.   Algros M.P.   Mougin C.   Bittard H.   Aubin F.  

European Journal of Cancer, Vol. 39, Iss. 5, 2003-03 ,pp. : 684-690

Elsevier

Access to resources Recommend Favorite

Growth Factor Requirement, Oncogene Expression and TP53 Mutations of a Tumorigenic and a Non-tumorigenic Subline of the Human Breast Carcinoma Cell Line, HMT-3909

By Madsen M.W.   Moyret C.   Theillet C.   Briand P.  

European Journal of Cancer, Vol. 31, Iss. 3, 1995-01 ,pp. : 362-367

Elsevier

Access to resources Recommend Favorite